September 2015   Pricing Sheet dated September 4, 2015 relating to Preliminary Terms No. 524 dated August 28, 2015 Registration Statement No. 333-200365 Filed pursuant to Rule 433

Structured Investments

Opportunities in U.S. Equities 

Contingent Income Auto-Callable Securities due September 7, 2018

Based on the Performance of the Common Stock of MetLife, Inc.

Principal at Risk Securities

PRICING TERMS- SEPTEMBER 4, 2015
Issuer:	Morgan Stanley
Underlying stock:	MetLife, Inc. common stock
Aggregate principal amount:	$1,034,500
Stated principal amount:	$10 per security
Issue price:	$10 per security
Pricing date:	September 4, 2015
Original issue date:	September 10, 2015 (3 business days after the pricing date)
Maturity date:	September 7, 2018
Early redemption:	If, on any of the first eleven determination dates, the determination closing price of the underlying stock is greater than or equal to the initial share price, the securities will be automatically redeemed for an early redemption payment on the third business day following the related determination date.  No further payments will be made on the securities once they have been redeemed.
Early redemption payment:	The early redemption payment will be an amount equal to (i) the stated principal amount plus (ii) the contingent quarterly coupon with respect to the related determination date.
Determination closing price:	The closing price of the underlying stock on any determination date other than the final determination date times the adjustment factor on such determination date
Contingent quarterly coupon:	· If, on any determination date, the determination closing price or the final share price, as applicable, is greater than or equal to the downside threshold level, we will pay a contingent quarterly coupon at an annual rate of 8.60% (corresponding to approximately $0.215 per quarter per security) on the related contingent payment date. · If, on any determination date, the determination closing price or the final share price, as applicable, is less than the downside threshold level, no contingent quarterly coupon will be paid with respect to that determination date.
Determination dates:	December 4, 2015, March 4, 2016, June 6, 2016, September 7, 2016, December 5, 2016, March 6, 2017, June 5, 2017, September 5, 2017, December 4, 2017, March 5, 2018, June 4, 2018 and September 4, 2018, subject to postponement for non-trading days and certain market disruption events.  We also refer to September 4, 2018 as the final determination date.
Contingent payment dates:	With respect to each determination date other than the final determination date, the third business day after the related determination date.  The payment of the contingent quarterly coupon, if any, with respect to the final determination date will be made on the maturity date.
Payment at maturity:	·  If the final share price is greater than or equal to the downside threshold level:			(i) the stated principal amount plus (ii) the contingent quarterly coupon with respect to the final determination date
	·  If the final share price is less than the downside threshold level:			(i) the stated principal amount multiplied by (ii) the share performance factor
Share performance factor:	Final share price divided by the initial share price
Adjustment factor:	1.0, subject to adjustment in the event of certain corporate events affecting the underlying stock
Downside threshold level:	$35.895, which is equal to 75% of the initial share price
Initial share price:	$47.86, which is equal to the closing price of the underlying stock on the pricing date
Final share price:	The closing price of the underlying stock on the final determination date times the adjustment factor on such date
CUSIP:	61765R230
ISIN:	US61765R2307
Listing:	The securities will not be listed on any securities exchange.
Agent:	Morgan Stanley & Co. LLC (“MS & Co.”), a wholly owned subsidiary of Morgan Stanley.  See “Supplemental information regarding plan of distribution; conflicts of interest” in the accompanying preliminary terms.
Estimated value on the pricing date:	$9.508 per security.  See “Investment Summary” in the accompanying preliminary terms.
Commissions and issue price:		Price to public	Agent’s commissions and fees		Proceeds to issuer(3)
Per security		$10	$0.20(1)		$9.75
			$0.05(2)
Total		$1,034,500	$25,862.50		$1,008,637.50

(1) Selected dealers, including Morgan Stanley Wealth Management (an affiliate of the agent), and their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $0.20 for each security they sell. For additional information, see “Supplemental information regarding plan of distribution; conflicts of interest” in the accompanying preliminary terms and “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

(2) Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.05 for each security.

(3) See “Use of proceeds and hedging” in the accompanying preliminary terms.

The securities are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.

You should read this document together with the preliminary terms describing the offering and the related product supplement and prospectus, each of which can be accessed via the hyperlinks below.

Preliminary Terms No. 524 dated August 28, 2015

Product Supplement for Auto-Callable Securities dated November 19, 2014Prospectus dated November 19, 2014

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.